Odds-On-Favorite Ubl Confirmed As Next PhRMA CEO

The Pharmaceutical Research and Manufacturers of America (PhRMA) late on Sept. 25 confirmed what had been widely speculated about in Washington and among industry insiders that AdvaMed CEO Stephen Ubl would be taking the reins as the next chief of the drug lobbying group.